The New Era of Pulmonary Hypertension: The Dawn of Disease Modification & Therapeutic Modalities

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research focuses on understanding pulmonary hypertension and exploring innovative treatment strategies to modify its disease course.
Assessment of pulmonary artery pressure through right heart catheterization
Evaluation of treatment modalities including vasodilators and novel therapies like sotatercept
Analysis of various etiologies contributing to pulmonary hypertension
Identified a prevalence of approximately 1% globally, with women more affected than men
Untreated pulmonary hypertension can result in significant health issues like cardio-renal syndrome
Novel treatments like sotatercept show promise in inhibiting processes that lead to excessive cell growth in pulmonary vasculature

Findings reveal interventions for managing pulmonary hypertension, indicating a shift towards disease modification.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Ramazani et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share